| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/07/2002 | CN1362094A Nano reinforced loquet medicine and its preparation |
| 08/07/2002 | CN1362093A Nano suxiaojiuxin medicine and its preparation |
| 08/07/2002 | CN1362092A Biantaoxian'an medicine for treating tonsillitis |
| 08/07/2002 | CN1362091A Nano antiphlogistic bezoar medicine and its preparation |
| 08/07/2002 | CN1362090A Nano energy-stagnation stomachache treating medicine and its preparation |
| 08/07/2002 | CN1362089A Nano sanhuang medicine and its preparation |
| 08/07/2002 | CN1362088A Nano nephritis treating medicine and its preparation |
| 08/07/2002 | CN1362087A Nano shengmai medicine and its preparation |
| 08/07/2002 | CN1362086A Nano Simiao medicine and its preparation |
| 08/07/2002 | CN1362085A Nano mixed natural indigo medicine and its preparation |
| 08/07/2002 | CN1362084A Nano coronary heart disease treating red sage medicine and its preparation |
| 08/07/2002 | CN1362083A Nano zuogui meidcine and its preparation |
| 08/07/2002 | CN1362082A Nano zhuifengtougu medicine and its preparation |
| 08/07/2002 | CN1362081A Nano tranquilizing cinnabar medicine and its preparation |
| 08/07/2002 | CN1362080A Nano zhengqing Fengtongning medicine and its preparation |
| 08/07/2002 | CN1362079A Nano Yuquan medicine and its preparation |
| 08/07/2002 | CN1362078A Nano indian chrysanthemum flower medicine and its preparation |
| 08/07/2002 | CN1362077A Nano thrombus treating xinmaining medicine and its preparation |
| 08/07/2002 | CN1362076A Nano thrombus dredging medicine and its preparation |
| 08/07/2002 | CN1362075A Nano blood stasis dispersing medicine and its preparation |
| 08/07/2002 | CN1362074A Nano heart proteoting medicine and its preparation |
| 08/07/2002 | CN1362073A Nano inflammation diminishing and gallbladder benefiting medicine and its preparation |
| 08/07/2002 | CN1362072A Nano heart nourishing medicine and its preparation |
| 08/07/2002 | CN1362066A Nano Bingpeng medicine and its prepn |
| 08/07/2002 | CN1362063A Nanometer polyporus umbrellatus polysaccharide medicine prepn and its prepn process |
| 08/07/2002 | CN1362060A Prepn of nano hydroxycamptothecine-dextran grain |
| 08/07/2002 | CN1362059A Nano Chinese medicine piece and its prepn |
| 08/07/2002 | CN1362025A Yangtao kernel oil capsule |
| 08/07/2002 | CN1362017A Mosquito repellent product and its production method |
| 08/07/2002 | CN1088698C Micro-particulate form of tetrahydropyridin derivatives |
| 08/07/2002 | CN1088599C Therapeutic compositions comprising antigen or an in vivo generator comprising amino-acid serial compounds |
| 08/07/2002 | CN1088592C Medicine for treating peptic ulcer |
| 08/07/2002 | CN1088591C Medicine for curing and preventing upper respiratory infection and stopping-smoking, and its preparing method |
| 08/07/2002 | CN1088590C Powdered medicine for treating beriberi |
| 08/07/2002 | CN1088587C Topical anti-inflammatory compositions containing piroxican |
| 08/07/2002 | CN1088584C Capsules for orae preparations and capsule preparations for oral administration |
| 08/07/2002 | CN1088583C Stable freeze-dried formulation comprising protein and assay kit |
| 08/07/2002 | CN1088582C Lipid-based carriers which can treat multiple diseases and have layered lipid componnets, their composition and use |
| 08/07/2002 | CN1088581C Aerosol formulations of peptides and proteins |
| 08/07/2002 | CN1088580C Aerosol drug formulations |
| 08/07/2002 | CN1088570C Food produced from wood frog oil and making method thereof |
| 08/06/2002 | US6429889 Laser marking discrete consumable articles |
| 08/06/2002 | US6429296 Complex of human growth hormone and zinc and use |
| 08/06/2002 | US6429232 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/06/2002 | US6429227 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/06/2002 | US6429224 Use of taurolidine to treat tumors |
| 08/06/2002 | US6429218 Applying a serum, cream, or lotion containing extra niacin to treat skin disorders such as acne, blackheads, fine lines, and enlarged pores; concentration is sufficient to produce warmth, blush, flushing or redness of skin |
| 08/06/2002 | US6429202 Administering complex with phospholipids to prevent atherosclerosis and myocardial or cerebral infarctions; reduces formation of arterial plaques |
| 08/06/2002 | US6429200 Negatively-charged, zwitterionic, or neutral complex for delivery to cell formed by inserting a nucleic acid into a negatively-charged, zwitterionic, or neutral reverse micelle wherein the nucleic acid is compacted |
| 08/06/2002 | US6429194 Mucin containing ophthalmic preparation |
| 08/06/2002 | US6428821 Oral micro-emulsion composition of silybin |
| 08/06/2002 | US6428820 Extracts of Hypericum perforatum and formulations containing them |
| 08/06/2002 | US6428818 Dietary or nutritional supplements and therapeutics for prevention and treatment of cancer; epicatechin and epigallocatechin gallate at 10:1 ratio; gallic acid free |
| 08/06/2002 | US6428817 Companion animal therapeutic treat |
| 08/06/2002 | US6428816 Inhibiting conversion of melanocyte cells to melanomas by modulating activity of a dna; beta-carotene in nontoxic carrier containing suspending agent, emulsifier and dispersing agent |
| 08/06/2002 | US6428815 Multifluid atomization of a dispersed system of a biologically active agent and a solvent to produce droplets; freezing the droplets; lyophilizing the frozen droplets obtain microstructures capable of being further fragmented |
| 08/06/2002 | US6428814 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 08/06/2002 | US6428813 Gastrointestinal mucosa-adherent pharmaceutical composition |
| 08/06/2002 | US6428812 Process for producing granules containing angiotensin-converting enzyme inhibiting peptides |
| 08/06/2002 | US6428810 Core material comprising active ingredient and optionally an alkalinity agent, hydroxypropyl cellulose separating layer and enteric coating; consistant release rate; storage stability |
| 08/06/2002 | US6428809 Metering and packaging of controlled release medication |
| 08/06/2002 | US6428808 Pharmaceutical composition prepared by addition of a flavor vehicle to a medicament |
| 08/06/2002 | US6428805 Powdery nasal compositions |
| 08/06/2002 | US6428804 Injectable microcapsules containing biodegradable, biocompat-ible high molecular weight polymer and therapeutic drug sus-pended in hyaluronic acid and/or chondroitin sulfate medium; inhibits side effects; long term efficacy |
| 08/06/2002 | US6428800 Mixture of bioactive glass and topical antibiotic |
| 08/06/2002 | US6428784 Vaginal suppository for treating group B Streptococcus infection |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/06/2002 | US6428772 Acne treatment composition with cooling effect |
| 08/06/2002 | US6428771 Method for drug delivery to the pulmonary system |
| 08/06/2002 | US6428770 Cleaning mouths by bubbling and dissolving tablets having triclosan, mints, menthol, chlorophylls and coatings of carbon dioxide emitters |
| 08/06/2002 | US6428769 Breathing aerosols to deposit particles of sildenafil citrate on the lungs; noninvasive therapy for sexual disorders; side effect reduction |
| 08/06/2002 | US6428529 Epidural administration of therapeutic compounds with sustained rate of release |
| 08/06/2002 | US6427681 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 08/05/2002 | CA2370355A1 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration |
| 08/01/2002 | WO2002059184A2 Molecular imprinting of small particles, and production of small particles from solid state reactants |
| 08/01/2002 | WO2002059147A2 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | WO2002059135A1 Compositions containing a ruthenium(iii) complex and a heterocycle |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002058790A1 Fluid retention assembly for an iontophoretic delivery |
| 08/01/2002 | WO2002058765A1 A drug delivery device |
| 08/01/2002 | WO2002058764A1 A drug delivery device |
| 08/01/2002 | WO2002058750A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 08/01/2002 | WO2002058749A2 Carrier with solid fibrinogen and solid thrombin |
| 08/01/2002 | WO2002058735A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | WO2002058718A2 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | WO2002058712A2 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 08/01/2002 | WO2002058708A1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 08/01/2002 | WO2002058705A2 Degradation-resistant glucocorticosteroid formulations |
| 08/01/2002 | WO2002058703A2 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | WO2002058701A1 Pharmaceutical dosage forms of epothilones for oral administration |
| 08/01/2002 | WO2002058700A1 Methods of administering epothilone analogs for the treatment of cancer |
| 08/01/2002 | WO2002058699A1 Pharmaceutical forms of epothilones for oral administration |
| 08/01/2002 | WO2002058689A1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same |
| 08/01/2002 | WO2002058688A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 08/01/2002 | WO2002058684A2 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 08/01/2002 | WO2002058678A2 Devices and methods for heat-pulse assisted thermal applications of active substances |
| 08/01/2002 | WO2002058677A1 New film coating |
| 08/01/2002 | WO2002058676A1 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
| 08/01/2002 | WO2002058674A2 Process for preparing particles |